BMS-986020 sodium
BMS-986020 sodium is a potent and selective LPA1 receptor antagonist used in research on idiopathic pulmonary fibrosis (IPF), where it has been shown to slow FVC decline in clinical studies. Its off-target inhibition of hepatic transporters like BSEP also makes it a relevant tool for investigating drug-induced liver injury and bile acid homeostasis in vitro.
Product Specifications
CAS Number
1380650-53-2
Product Name Alternative
BMS986020 sodium, AM152 sodium, AM-152 sodium
Field of Research
Pharmacology & Drug Discovery
Purity
99.83% (May vary between batches)
Solubility
DMSO:120 mg/mL (237.85 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:5 mg/mL (9.91 mM)
Smiles
[O-]C (C1 (C2=CC=C (C3=CC=C (C4=C (C (C) =NO4) NC (O[C@@H] (C5=CC=CC=C5) C) =O) C=C3) C=C2) CC1) =O.[Na+]
Molecular Formula
C29H25N2NaO5
Molecular Weight
504.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
UQCRC1 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
ZNF350 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated